Advances in psychiatry and nuerology


ISSN 1230-2813
ISSN online 2720-5371 

JCR Impact Factor: 1,0
CiteScore 2024: 1.4
MNiSW: 70
Index Copernicus 2023: 153.00

Indexed in PubMed.

We encourage our Readers to continue, renew or start a subscription to the quarterly in 2025. The journal needs your support – to become better and better and to be able to offer you more.

Editorial panel
Submitting and reviewing works online
  • Home page
  • >
  • Archive
  • >
  • zeszyt 4
  • >
  • Contemporary views on the role of dopamine agonists in the treatment of Parkinson’s disease

Archive 1992–2014

2002, tom 11, zeszyt 4
Parkinson's disease

Contemporary views on the role of dopamine agonists in the treatment of Parkinson’s disease

Włodzimierz Kuran1
1. I Klinika Neurologiczna Instytutu Psychiatrii i Neurologii w Warszawie
Postępy Psychiatrii i Neurologii, 2002, 11, 383-390
Keywords: Parkinson’s disease, dopamine agonists’
Summary

Contemporary experience and views concerning dopamine agonists' application in the treatment of Parkinson's disease are presented in the paper. Particular medications, mechanisms of their action, as well as their advantages and disadvantages are discussed, and their effectiveness and safety are compared. Finally, basic recommendations for these drugs administration are proposed, with the emphasis on individual circumstances that have to be taken into account in each case. (Ed.)

Correspondence address
Adres: I Klinika Neurologiczna Instytutu Psychiatrii i Neurologii,
ul. Sobieskiego 9, 02-957 Warszawa
You have added an item to your cart
Restore password
Shopping cart (0)
No products in your cart
Font size
Contrast
Underlined links